BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31821410)

  • 41. Berberine Attenuates Cardiac Hypertrophy Through Inhibition of mTOR Signaling Pathway.
    Chen X; Jiang X; Cheng C; Chen J; Huang S; Xu M; Liu S
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):463-473. PubMed ID: 32394178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling.
    Nijholt KT; Sánchez-Aguilera PI; Booij HG; Oberdorf-Maass SU; Dokter MM; Wolters AHG; Giepmans BNG; van Gilst WH; Brown JH; de Boer RA; Silljé HHW; Westenbrink BD
    Sci Rep; 2023 Mar; 13(1):4046. PubMed ID: 36899057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sirtuin 1 activation attenuates cardiac fibrosis in a rodent pressure overload model by modifying Smad2/3 transactivation.
    Bugyei-Twum A; Ford C; Civitarese R; Seegobin J; Advani SL; Desjardins JF; Kabir G; Zhang Y; Mitchell M; Switzer J; Thai K; Shen V; Abadeh A; Singh KK; Billia F; Advani A; Gilbert RE; Connelly KA
    Cardiovasc Res; 2018 Oct; 114(12):1629-1641. PubMed ID: 29800064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.
    Higashikuni Y; Tanaka K; Kato M; Nureki O; Hirata Y; Nagai R; Komuro I; Sata M
    J Am Heart Assoc; 2013 Nov; 2(6):e000267. PubMed ID: 24249711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes.
    Ago T; Kuroda J; Pain J; Fu C; Li H; Sadoshima J
    Circ Res; 2010 Apr; 106(7):1253-64. PubMed ID: 20185797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.
    Ren L; Wu C; Yang K; Chen S; Ye P; Wu J; Zhang A; Huang X; Wang K; Deng P; Ding X; Chen M; Xia J
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.
    Zhao L; Cheng G; Jin R; Afzal MR; Samanta A; Xuan YT; Girgis M; Elias HK; Zhu Y; Davani A; Yang Y; Chen X; Ye S; Wang OL; Chen L; Hauptman J; Vincent RJ; Dawn B
    Circ Res; 2016 Jun; 118(12):1918-1929. PubMed ID: 27126808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NADPH Oxidase 4 Regulates Inflammation in Ischemic Heart Failure: Role of Soluble Epoxide Hydrolase.
    Stevenson MD; Canugovi C; Vendrov AE; Hayami T; Bowles DE; Krause KH; Madamanchi NR; Runge MS
    Antioxid Redox Signal; 2019 Jul; 31(1):39-58. PubMed ID: 30450923
    [No Abstract]   [Full Text] [Related]  

  • 49. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
    Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways.
    Honsho S; Nishikawa S; Amano K; Zen K; Adachi Y; Kishita E; Matsui A; Katsume A; Yamaguchi S; Nishikawa K; Isoda K; Riches DW; Matoba S; Okigaki M; Matsubara H
    Circ Res; 2009 Nov; 105(11):1149-58. PubMed ID: 19834007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NADPH oxidase 4 mediates the protective effects of physical activity against obesity-induced vascular dysfunction.
    Brendel H; Shahid A; Hofmann A; Mittag J; Bornstein SR; Morawietz H; Brunssen C
    Cardiovasc Res; 2020 Aug; 116(10):1767-1778. PubMed ID: 31800011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
    Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
    J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
    Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
    Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The N
    Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
    Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ryanodine receptor type 2 is required for the development of pressure overload-induced cardiac hypertrophy.
    Zou Y; Liang Y; Gong H; Zhou N; Ma H; Guan A; Sun A; Wang P; Niu Y; Jiang H; Takano H; Toko H; Yao A; Takeshima H; Akazawa H; Shiojima I; Wang Y; Komuro I; Ge J
    Hypertension; 2011 Dec; 58(6):1099-110. PubMed ID: 21986507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogen receptor antagonism exacerbates cardiac structural and functional remodeling in female rats.
    El Hajj MC; Ninh VK; El Hajj EC; Bradley JM; Gardner JD
    Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H98-H105. PubMed ID: 27769996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats.
    Wang H; Jessup JA; Lin MS; Chagas C; Lindsey SH; Groban L
    Cardiovasc Res; 2012 Apr; 94(1):96-104. PubMed ID: 22328091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.
    Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M
    Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy.
    Matsushima S; Kuroda J; Ago T; Zhai P; Park JY; Xie LH; Tian B; Sadoshima J
    Circ Res; 2013 Feb; 112(4):651-63. PubMed ID: 23271793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.